Neuroscientists identify cells especially vulnerable to Alzheimer’s
Neurons that form part of a memory circuit are among the first brain cells to show signs of neurodegeneration in Alzheimer’s disease.
Neurons that form part of a memory circuit are among the first brain cells to show signs of neurodegeneration in Alzheimer’s disease.
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
A new study identifies cells that are the most vulnerable within a brain structure involved in mood and movement.
MLK Visiting Professor tries to “maximize connection time” while studying protein evolution.
Harnessing these protective molecules may offer a new way to treat the disease, which spreads through contaminated water.
Researchers used a powerful deep-learning model to extract important data from electronic health records that could assist with personalized medicine.
Known as PASTE, the technique holds potential for treating a variety of diseases caused by faulty genes.
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
At an exhibition marking two decades since a transformative gift from the Picower Foundation, current and alumni members described research at the forefront of neuroscience and beyond.
“AI for endometriosis? If only there were data!”
Test that measures a person’s antibodies requires a drop of blood and takes just 10 minutes to show results.
A machine-learning method finds patterns of health decline in ALS, informing future clinical trial designs and mechanism discovery. The technique also extends to Alzheimer’s and Parkinson’s.
By continuously monitoring a patient’s gait speed, the system can assess the condition’s severity between visits to the doctor’s office.
A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.